Douglas E. Brough
Corporate Officer/Principal bei PRECIGEN, INC.
Aktive Positionen von Douglas E. Brough
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Douglas E. Brough
Ehemalige bekannte Positionen von Douglas E. Brough
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENVEC INC | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2013 | 16.06.2017 |
Ausbildung von Douglas E. Brough
| Purdue University | Undergraduate Degree |
| Idaho State University | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
- Börse
- Insiders
- Douglas E. Brough
- Erfahrung
